Sort
10,829 grants matching “car t”
SBIR Phase II: Automotive Nanocomposites
$873,000Joel Dulebohn · Inpore Technologies, Inc. · · FY2008 · TIP
Low-cost Mobile Oral Cancer Screening for Low Resource Setting
$871,344Rongguang Liang · University Of Arizona · UH3 · FY2019 · CA
NextGen - CRI
$871,168Catherine Mary Bollard · Children'S Research Institute · OT2 · FY2022 · CA
Maryland Prostate Cancer Case-Control Study
$869,296Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies
$868,770Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Center for Cell-based Therapy - Cures
$867,748Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Iomab-ACT: A phase I/II study of 131-I apamistamab targeted lymphodepletion followed by CD19-targeted CAR T-cell therapy for patients with relapsed or refractory B-ALL or DLBCL
$865,308Avinash Desai · Actinium Pharmaceuticals, Inc. · R42 · FY2024 · CA
Iomab-ACT: A phase I/II study of 131-I apamistamab targeted lymphodepletion followed by CD19-targeted CAR T-cell therapy for patients with relapsed or refractory B-ALL or DLBCL
$865,308Avinash Desai · Actinium Pharmaceuticals, Inc. · R42 · FY2023 · CA
SBIR Phase II: High Performance Structural Composites with Cellulosic Nanoparticles
$865,244Elisa Teipel · Essentium Materials Llc · · FY2016 · TIP
Xenobiotic Receptors in Mediating the Environmental Effects on Human Disease and Morbidity
$864,263Wen Xie · University Of Pittsburgh At Pittsburgh · R35 · FY2022 · ES
Innovation of Biobanking for Cellular Adoptive Immunotherapies Based on a First-in-Class Biocompatible Cryopreservation Technology for T and NK Cells and Their CAR-Engineered Products
$864,173Xu Han · Cryocrate, Llc · R44 · FY2023 · CA
Programming T Cell Fates for Therapeutic Use
$864,150Luca Gattinoni · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
BCMA Specific Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Patients with Multiple Myeloma
$862,729Damian J. Green · Fred Hutchinson Cancer Center · P01 · FY2022 · CA
Advancing artificial intelligence algorithms for cervical cancer diagnostics
$862,442Sameer Antani · National Library Of Medicine · ZIA · FY2020 · LM
Selective Targeting of the PD-1+ HIV/SIV reservoir with novel anti-PD-1 chimeric antigen receptor T cells
$862,398Karsten Eichholz · Fred Hutchinson Cancer Center · R01 · FY2025 · AI
BCMA Specific Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Patients with Multiple Myeloma
$861,992Damian J. Green · Fred Hutchinson Cancer Research Center · P01 · FY2020 · CA
BCMA Specific Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Patients with Multiple Myeloma
$859,480Damian J. Green · Fred Hutchinson Cancer Research Center · P01 · FY2021 · CA
NIEHS Knock Out Core (KOC) Annual Report-2009
$859,172Manas Ray · National Institute Of Environmental Health Sciences · ZIG · FY2009 · ES
Smartphone App to Increase and Maintain Physical Activity in African American Men (FitBrothers)
$859,118Robert Lee Newton · Klein Buendel, Inc. · R42 · FY2022 · MD
Study of CAR T cells and mechanisms of resistance in pediatric brain tumors
$858,635Anandani Nellan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy
$858,502Joshua Aiden Hill · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
mLab App for Improving Uptake of rapid HIV self-testing and Linking Youth to Care
$856,952Rebecca Schnall · Columbia University Health Sciences · R01 · FY2018 · MH
Evaluation of Vectors based on group B adenoviruses
$855,992Andre Michael Lieber · University Of Washington · R01 · FY2013 · CA
Enhancing the Effectiveness of Community Health Workers to Reduce Cervical Cancer Disparities in African American Women
$855,861Douglas W Billings · Isa Associates, Inc. · R44 · FY2022 · MD
Xenobiotic Receptors in Mediating the Environmental Effects on Human Disease and Morbidity
$855,738Wen Xie · University Of Pittsburgh At Pittsburgh · R35 · FY2023 · ES